Estrogen therapy and urinary incontinence: What is the evidence and what do we tell our patients?

International Urogynecology Journal

Volumn 17, Issue 5, 2006, Pages 541-545

  Waetjen, L Elaine ^a   Dwyer, Peter L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CENTCHROMAN; CONJUGATED ESTROGEN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE; RALOXIFENE;

ADRENERGIC ACTIVITY; CLINICAL TRIAL; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG WITHDRAWAL; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HORMONE ACTION; HUMAN; INCIDENCE; MENSTRUAL CYCLE; NONHUMAN; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; STRESS INCONTINENCE; TREATMENT OUTCOME; TREATMENT RESPONSE; URGE INCONTINENCE; URINE INCONTINENCE;

EID: 33746558057     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-006-0080-3     Document Type: Review

References (42)

1. Fantl JA, Cardozo L, McClish DK (1994) Estrogen therapy in the management of urinary incontinence in postmenopausal women: A meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 83(1):12-18
2. Elia G, Bergman A (1993) Estrogen effects on the urethra: Beneficial effects in women with genuine stress incontinence. Obstet Gynecol Surv 48(7):509-517
3. Sacco F, Rigon G, Carbone A, Sacchini D (1990) Transvaginal estrogen therapy in urinary stress incontinence. Minerva Ginecol 42(12):539-544
4. Jarmy-Di Bella ZI, Girao MJ, Sartori MF et al (2000) Power Doppler of the urethra in continent or incontinent, pre- and postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct 11(3):148-154, Discussion 154-145
5. Beisland HO, Fossberg E, Moer A, Sander S (1984) Urethral sphincteric insufficiency in postmenopausal females: Treatment with phenylpropanolamine and estriol separately and in combination. A urodynamic and clinical evaluation. Urol Int 39(4):211-216
6. Creed KE (1983) Effect of hormones on urethral sensitivity to phenylephrine in normal and incontinent dogs. Res Vet Sci 34(2):177-181
7. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L (1998) Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: Second report of the Hormones and Urogenital Therapy Committee. Obstetrics and Gynecology 92:722-727
8. Moehrer B, Hextall A, Jackson S (2003) Oestrogens for urinary incontinence in women (Cochrane Review). Cochrane Database Syst Rev (2):CD001405
9. Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T (2001) Postmenopausal hormones and incontinence: The Heart and Estrogen/ Progestin Replacement Study. Obstet Gynecol 97(1):116-120
10. Hendrix SL, Cochrane BB, Nygaard IE et al (2005) Effects of estrogen with and without progestin on urinary incontinence. JAMA 293(8):935-948
11. Steinauer JE, Waetjen LE, Vittinghoff E et al (2005) Postmenopausal hormone therapy: Does it cause incontinence? Obstet Gynecol 106(5):940-945
12. Gebhardt J, Richard D, Barrett T (2001) Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women. Am J Obstet Gynecol 185:1325-1330
13. Copas P, Bukovsky A, Asbury B, Elder RF, Caudle MR (2001) Estrogen, progesterone, and androgen receptor expression in levator ani muscle and fascia. J Womens Health Gend Based Med 10(8):785-795
14. Smith P, Heimer G, Norgren A, Ulmsten U (1990) Steroid hormone receptors in pelvic muscles and ligaments in women. Gynecol Obstet Investig 30(1):27-30
15. Fu X, Rezapour M, Wu X, Li L, Sjogren C, Ulmsten U (2003) Expression of estrogen receptor-alpha and -beta in anterior vaginal walls of genuine stress incontinent women. Int Urogynecol J Pelvic Floor Dysfunct 14(4):276-281, discussion 281
16. Zoubina EV, Smith PG (2003) Expression of estrogen receptors alpha and beta by sympathetic ganglion neurons projecting to the proximal urethra of female rats. J Urol 169(1):382-385, Jan
17. Keane DP, Sims TJ, Abrams P, Bailey AJ (1997) Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence. Br J Obstet Gynaecol 104(9):994-998
18. Falconer C, Ekman-Ordeberg G, Blomgren B et al (1998) Paraurethral connective tissue in stress-incontinent women after menopause. Acta Obstet Gynecol Scand 77(1):95-100
19. Jackson S, James M, Abrams P (2002) The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. BJOG 109(3):339-344
20. Aikawa K, Sugino T, Matsumoto S, Chichester P, Whitbeck C, Levin RM (2003) The effect of ovariectomy and estradiol on rabbit bladder smooth muscle contraction and morphology. J Urol 170:634-637
21. Sartori MG, Girao MJ, de Jesus Simoes M, Sartori JP, Baracat EC, Rodrigues de Lima G (2001) Quantitative evaluation of collagen and muscle fibers in the lower urinary tract of castrated and under-hormone replacement female rats. Clin Exp Obstet Gynecol 28(2):92-96
22. Fleischmann N, Christ G, Sclafani T, Melman A (2002) The effect of ovariectomy and long-term estrogen replacement on bladder structure and function in the rat. J Urol 168(3):1265-1268
23. Endo RM, Girao MJ, Sartori MG, Simoes MJ, Baracat EC, Rodrigues de Lima G (2000) Effect of estrogen-progestogen hormonal replacement therapy on periurethral and bladder vessels. Int Urogynecol J Pelvic Floor Dysfunct 11(2):120-123
24. Robinson D, Rainer RO, Washburn SA, Clarkson TB (1996) Effects of estrogen and progestin replacement on the urogenital tract of the ovariectomized cynomolgus monkey. Neurourol Urodyn 15(3):215-221
25. Zoubina EV, Mize AL, Alper RH, Smith PG (2001) Acute and chronic estrogen supplementation decreases uterine sympathetic innervation in ovariectomized adult virgin rats. Histol Histopathol 16(4):989-996
26. Hendrix SL, McNeeley SG (2001) Effect of selective estrogen receptor modulators on reproductive tissues other than endometrium. Ann N Y Acad Sci 949:243-250
27. Waetjen LE, Brown JS, Modelska K, Blackwell T, Vittinghoff E, Cummings SR (2004) Effect of raloxifene on urinary incontinence: A randomized controlled trial. Obstet Gynecol 103(2):261-266
28. Samsioe G, Jansson I, Mellstrom D, Svanborg A (1985) Occurrence, nature and treatment of urinary incontinence in a 70-year-old female population. Maturitas 7(4):335-342
29. Rufford J, Hextall A, Cardozo L, Khullar V (2003) A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct 14(2):78-83
30. Grodstein F, Lifford K, Resnick NM, Curhan GC (2004) Postmenopausal hormone therapy and risk of developing urinary incontinence. Obstet Gynecol 103(2):254-260
31. Waetjen LE, Brown JS, Vittinghoff E et al (2005) The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women. Obstet Gynecol 106(5):946-952
32. Henalla SM, Millar DR, Wallace KJ (1990) Surgical versus conservative management for post-menopausal genuine stress incontinence of urine (abstract).Neurourol Urodyn 9(4):436-437
33. Cardozo LD, Wise BG, Benness CJ (2001) Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal women - a double-blind placebo-controlled study. J Obstet Gynaecol 21(4):383-385
34. Enzelsberger H, Kurz C, Schatten C, Huber J (1991) The effectiveness of intravaginal estriol tablet administration in women with urge incontinence. Geburtshilfe Frauenheilkd 51(10):834-838
35. Assassa RP, Jagger C, Williams K, McGrother C, Mayne C (2003) Randomised double-blind placebo controlled trial of topical oestrogen in the treatment of female bladder symptoms. Int Urogynecol J 14(Suppl 1):S43
36. Cardozo L, Rekers H, Tapp A et al (1993) Oestriol in the treatment of postmenopausal urgency: A multicentre study. Maturitas 18(1):47-53
37. Jackson S, Shepherd A, Brookes S, Abrams P (1999) The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: A double-blind placebo-controlled trial. Br J Obstet Gynaecol 106(7):711-718
38. Hextall A, Bidmead J, Cardozo L, Hooper R (2001) The impact of the menstrual cycle on urinary symptoms and the results of urodynamic investigation. Bjog 108(11):1193-1196
39. Raz S, Zeigler M, Caine M (1973) The effect of progesterone on the adrenergic receptors of the urethra. Br J Urol 45(2):131-135
40. Ouslander JG, Greendale GA, Uman G, Lee C, Paul W, Schnelle J (2001) Effects of oral estrogen and progestin on the lower urinary tract among female nursing home residents. J Am Geriatr Soc 49(6):803-807
41. Goldstein SR, Johnson S, Watts NB, Ciaccia AV, Elmerick D, Muram D (2005) Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen. Menopause 12(2):160-164
42. Wilson PD, Faragher B, Butler B, Bu'Lock D, Robinson EL, Brown AD (1987) Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women. Br J Obstet Gynaecol 94(6):568-574